Paul Hartmann aims to increase profits by up to 15% in 2025. The defensive qualities should support the new upward movement!

So far, few companies have dared to provide a forecast for 2025. However, one of them is the small-cap company Paul Hartmann (747404), as the group outlined today. Paul Hartmann specializes in wound management and infection management. To this end, they offer wound dressings, diagnostic devices, surgical covering systems, clothing, and disinfection solutions. In 2024, they raised their forecast several times and last expected an EBITDA of 230 to 270 million euros. As reported today, EBITDA grew by 29% to 261 million euros. The group landed in...